StockData
CRISPR Therapeutics AG logo

CRISPR Therapeutics AG (CRSP) stock

CRSPNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 8/30
$40.19+0.04 (+0.10%)

Close on Nov 18, 2026Market cap $3.89BP/E –Yield –

CRISPR Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

CRISPR Therapeutics's market cap was $4.42B on Nov 11, 2026, against $5.02B a year earlier. Over the last 5 years it ranged from $2.92B to $6.74B, with a median of $4.58B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$4.42B-10.2%
2025Dec 31, 2025$4.92B+46.6%
2024Dec 31, 2024$3.36B-32.4%
2023Dec 29, 2023$4.97B+56.3%
2022Dec 30, 2022$3.18B-45.1%
2021Dec 31, 2021$5.79B-46.4%
2020Dec 31, 2020$10.81B+221.6%
2019Dec 31, 2019$3.36B+128.2%
2018Dec 31, 2018$1.47B+55.3%
2017Dec 29, 2017$948.17M+781.7%
2016Dec 30, 2016$107.54M–

More CRISPR Therapeutics figures

See a number that looks wrong?